Shares of Cencora Inc. COR advanced 1.22% to $264.14 Tuesday, on what proved to be an all-around dismal trading session for ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great ...

We recently published a list of Top 10 Insider Sales Last Month. In this article, we are going to take a look at where ...

Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging population. Learn more on COR stock here.

Wells Fargo raised the firm’s price target on Cencora (COR) to $274 from $251 and keeps an Equal Weight rating on the shares. The firm is ...

Dispensary of Hope, Viatris, and Cencora launched a groundbreaking initiative to identify unused, short-dated medications at ...

Proficio Capital Partners LLC bought a new position in Cencora, Inc. (NYSE:COR – Free Report) in the 4th quarter, according ...

Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...

This medical supplies distributor raised its 2025 earnings outlook on Monday. Cencora stock is near a buy point of a newly formed base. Cencora (NYSE:COR) has made headlines with its announcement ...

Cencora (NYSE:COR) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Cencora (NYSE:COR – Get Free Report) had its price objective increased by analysts at Wells Fargo & Company from $251.00 to $274.00 in a report released on Friday,Benzinga reports.The firm ...

With the capital infusion, Lumata will look to grow its headcount from more than 200 to about 400 to meet surging demand.